肠道菌群与缺血性脑卒中相关研究进展

doi:10.3969/j.issn.1674-490X.2021.06.002

摘要/Abstract

摘要： 肠道菌群是目前国内外学者研究的热点问题,缺血性脑卒中后肠道菌群的结构及组成会发生改变,可能会对卒中后人群的生命健康产生威胁。肠道菌群通过增加促炎细胞因子的产生及肠道通透性等机制影响疾病的进展。通过菌群与卒中相关炎症反应、缺血性脑卒中后患者肠道菌群的变化、菌群对脑卒中并发症的影响和目前肠道菌群用于临床治疗的可能性对肠道菌群与缺血性脑卒中的研究进展进行综述。在临床诊治过程中,应考虑到肠道菌群的影响,以免影响疾病的诊断和治疗。

关键词: 肠道菌群, 缺血性脑卒中, 并发症, 治疗

Abstract: Intestinal flora is currently a hot issue studied by scholars around the world. The structure and composition of intestinal flora will change after ischemic stroke, which may threaten the life and health of people after stroke. Intestinal flora affects the progression of the disease by increasing the production of pro-inflammatory cytokines and intestinal permeability. Through the flora and stroke-related inflammatory response, the changes in the intestinal flora of patients after ischemic stroke, the impact of the flora on the complications of stroke, and the possibility of the current intestinal flora for clinical treatment, the progress of the intestinal flora and ischemic stroke were reviewed. In the process of clinical diagnosis and treatment, the influence of intestinal flora should be considered so as not to affect the diagnosis and treatment of the disease.

Key words: intestinal flora, ischemic stroke, complications, treatment

中图分类号:

张孟繁,王秀丽,路潇,张文会,梁璐. 肠道菌群与缺血性脑卒中相关研究进展[J]. 医学研究与教育, 2021, 38(6): 8-14.

参考文献

[1] BENJAMIN E J, VIRANI S S, CALLAWAY C W, et al. Heart disease and stroke statistics-2018 update: a report from the American heart association[J]. Circulation, 2018, 137(12): e67-e492. DOI: 10.1161/CIR.0000000000000558.
[2] KAESMACHER J, KLEINE J F. Bridging therapy with i.v. rtPA in MCA occlusion prior to endovascular thrombectomy: a double-edged sword?[J]. Clin Neuroradiol, 2018, 28(1): 81-89. DOI: 10.1007/s00062-016-0533-0.
[3] YANG P F, ZHANG Y W, ZHANG L, et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke[J]. N Engl J Med, 2020, 382(21): 1981-1993. DOI: 10.1056/NEJMoa2001123.
[4] PLUTA R, JANUSZEWSKI S, CZUCZWAR S J. The role of gut microbiota in an ischemic stroke[J]. Int J Mol Sci, 2021, 22(2): E915. DOI: 10.3390/ijms22020915.
[5] NAM H S. Gut microbiota and ischemic stroke: the role of trimethylamine N-oxide[J]. J Stroke, 2019, 21(2): 151-159. DOI: 10.5853/jos.2019.00472.
[6] ALMEIDA A, NAYFACH S, BOLAND M, et al. A unified catalog of 204 938 reference genomes from the human gut microbiome[J]. Nat Biotechnol, 2021, 39(1): 105-114. DOI: 10.1038/s41587-020-0603-3.
[7] ECKBURG P B, BIK E M, BERNSTEIN C N, et al. Diversity of the human intestinal microbial flora[J]. Science, 2005, 308(5728): 1635-1638. DOI: 10.1126/science.1110591.
[8] FALONY G, JOOSSENS M, VIEIRA-SILVA S, et al. Population-level analysis of gut microbiome variation[J]. Science, 2016, 352(6285): 560-564. DOI: 10.1126/science.aad3503.
[9] HOULDEN A, GOLDRICK M, BROUGH D, et al. Brain injury induces specific changes in the caecal microbiota of mice via altered autonomic activity and mucoprotein production[J]. Brain Behav Immun, 2016, 57: 10-20. DOI: 10.1016/j.bbi.2016.04.003.
[10] CRYAN J F, O'RIORDAN K J, COWAN C S M, et al. The microbiota-gut-brain axis[J]. Physiol Rev, 2019, 99(4): 1877-2013. DOI: 10.1152/physrev.00018.2018.
[11] BONSACK B, JIANG R H, BORLONGAN C V. A gut feeling about stroke reveals gut-brain axis' active role in homeostasis and dysbiosis[J]. J Cereb Blood Flow Metab, 2020, 40(5): 1132-1134. DOI: 10.1177/0271678X19900037.
[12] CANDELARIO-JALIL E, PAUL S. Impact of aging and comorbidities on ischemic stroke outcomes in preclinical animal models: a translational perspective[J]. Exp Neurol, 2021, 335: 113494. DOI: 10.1016/j.expneurol.2020.113494.
[13] BENAKIS C, POON C, LANE, et al. Distinct commensal bacterial signature in the gut is associated with acute and long-term protection from ischemic stroke[J]. Stroke, 2020, 51(6): 1844-1854. DOI: 10.1161/STROKEAHA.120.029262.
[14] ZHAO L, XIONG Q T, STARY C M, et al. Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke[J]. J Neuroinflammation, 2018, 15(1): 339. DOI: 10.1186/s12974-018-1382-3.
[15] SINGH V, SADLER R, HEINDL S, et al. The gut microbiome primes a cerebroprotective immune response after stroke[J]. J Cereb Blood Flow Metab, 2018, 38(8): 1293-1298. DOI: 10.1177/0271678X18780130.
[16] WEN S W, WONG C H Y. An unexplored brain-gut microbiota axis in stroke[J]. Gut Microbes, 2017, 8(6): 601-606. DOI: 10.1080/19490976.2017.1344809.
[17] STANLEY D, MASON L J, MACKIN K E, et al. Translocation and dissemination of commensal bacteria in post-stroke infection[J]. Nat Med, 2016, 22(11): 1277-1284. DOI: 10.1038/nm.4194.
[18] LUKIW W J, CONG L, JABER V, et al. Microbiome-derived lipopolysaccharide(LPS)selectively inhibits neurofilament light chain(NF-L)gene expression in human neuronal-glial(HNG)cells in primary culture[J]. Front Neurosci, 2018, 12: 896. DOI: 10.3389/fnins.2018.00896.
[19] YAMASHIRO K, TANAKA R, URABE T, et al. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke[J]. PLoS One, 2017, 12(2): e0171521. DOI: 10.1371/journal.pone.0171521.
[20] CHEN Y H, LIANG J H, OUYANG F B, et al. Persistence of gut microbiota dysbiosis and chronic systemic inflammation after cerebral infarction in cynomolgus monkeys[J]. Front Neurol, 2019, 10: 661. DOI: 10.3389/fneur.2019.00661.
[21] SINGH V, ROTH S, LLOVERA G, et al. Microbiota dysbiosis controls the neuroinflammatory response after stroke[J]. J Neurosci, 2016, 36(28): 7428-7440. DOI: 10.1523/JNEUROSCI.1114-16.2016.
[22] SADLER R, SINGH V, BENAKIS C, et al. Microbiota differences between commercial breeders impacts the post-stroke immune response[J]. Brain Behav Immun, 2017, 66: 23-30. DOI: 10.1016/j.bbi.2017.03.011.
[23] BENAKIS C, BREA D, CABALLERO S, et al. Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells[J]. Nat Med, 2016, 22(5): 516-523. DOI: 10.1038/nm.4068.
[24] SHERWIN E, DINAN T G, CRYAN J F. Recent developments in understanding the role of the gut microbiota in brain health and disease[J]. Ann N Y Acad Sci, 2018, 1420(1): 5-25. DOI: 10.1111/nyas.13416.
[25] XU N, KAN P C, YAO X H, et al. Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice[J]. J Microbiol, 2018, 56(11): 838-846. DOI: 10.1007/s12275-018-8327-5.
[26] LI N, WANG X C, SUN C C, et al. Change of intestinal microbiota in cerebral ischemic stroke patients[J]. BMC Microbiol, 2019, 19(1): 191. DOI: 10.1186/s12866-019-1552-1.
[27] JI W Z, ZHU Y, KAN P C, et al. Analysis of intestinal microbial communities of cerebral infarction and ischemia patients based on high throughput sequencing technology and glucose and lipid metabolism[J]. Mol Med Rep, 2017, 16(4): 5413-5417. DOI: 10.3892/mmr.2017.7227.
[28] STANLEY D, MOORE R J, WONG C H Y. An insight into intestinal mucosal microbiota disruption after stroke[J]. Sci Rep, 2018, 8(1): 568. DOI: 10.1038/s41598-017-18904-8.
[29] MEISEL C, PRASS K, BRAUN J, et al. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke[J]. Stroke, 2004, 35(1): 2-6. DOI: 10.1161/01.str.0000109041.89959.4c.
[30] LIU P, WU L, PENG G, et al. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort[J]. Brain Behav Immun, 2019, 80: 633-643. DOI: 10.1016/j.bbi.2019.05.008.
[31] LI D, KE Y L, ZHAN R, et al. Trimethylamine-N-oxide promotes brain aging and cognitive impairment in mice[J]. Aging Cell, 2018, 17(4): e12768. DOI: 10.1111/acel.12768.
[32] SUN J, LING Z X, WANG F Y, et al. Clostridium butyricum pretreatment attenuates cerebral ischemia/reperfusion injury in mice via anti-oxidation and anti-apoptosis[J]. Neurosci Lett, 2016, 613: 30-35. DOI: 10.1016/j.neulet.2015.12.047.
[33] LIU Y Q, KONG C, GONG L, et al. The association of post-stroke cognitive impairment and gut microbiota and its corresponding metabolites[J]. J Alzheimers Dis, 2020, 73(4): 1455-1466. DOI: 10.3233/JAD-191066.
[34] ZHENG P, ZENG B, ZHOU C, et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism[J]. Mol Psychiatr, 2016, 21(6): 786-796. DOI: 10.1038/mp.2016.44.
[35] 范文涛, 闫咏梅, 别玉龙, 等. 脑卒中后抑郁症患者肠道菌群的多样性分析[J]. 南方医科大学学报, 2016, 36(10): 1305-1311.
[36] SUN J, WANG F Y, LING Z X, et al. Clostridium butyricum attenuates cerebral ischemia/reperfusion injury in diabetic mice via modulation of gut microbiota[J]. Brain Res, 2016, 1642: 180-188. DOI: 10.1016/j.brainres.2016.03.042.
[37] CHESNOKOVA V, PECHNICK R N, WAWROWSKY K. Chronic peripheral inflammation, hippocampal neurogenesis, and behavior[J]. Brain Behav Immun, 2016, 58: 1-8. DOI: 10.1016/j.bbi.2016.01.017.
[38] PAN F W, ZHANG L Y, LI M, et al. Predominant gut Lactobacillus murinus strain mediates anti-inflammaging effects in calorie-restricted mice[J]. Microbiome, 2018, 6(1): 54. DOI: 10.1186/s40168-018-0440-5.
[39] 冯云,亢君君,方宗平,等.肠道菌群移植通过降低IL-17水平减轻老年小鼠脑缺血再灌注损伤[J].细胞与分子免疫学杂志,2019,35(1):52-57.
[40] HWANG Y H, PARK S, PAIK J W, et al. Efficacy and safety of Lactobacillus plantarum C29-fermented soybean(DW2009)in individuals with mild cognitive impairment: a 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial[J]. Nutrients, 2019, 11(2): 305. DOI: 10.3390/nu11020305.
[41] DE FILIPPIS F, PELLEGRINI N, VANNINI L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome[J]. Gut, 2016, 65(11): 1812-1821. DOI: 10.1136/gutjnl-2015-309957.